STAT+: ARPA-H launches $160 million effort to develop custom gene editing drugs
From the article
You might also wanna read
Jackson Laboratory and Broad Institute receive $34.5M ARPA-H award for pediatric epilepsy gene editing platform
The Jackson Laboratory (JAX), in partnership with the Broad Institute and other collaborators, has been selected for an up to $34.5 million
jax.org·2h ago
High-cost gene therapies face financing barriers in US healthcare system
Gene therapies costing $2 million or more per patient can cure diseases like sickle cell with a single treatment, but America's healthcare s
statnews.com·29d ago
How Taxpayer-Funded Research Led to a $2 Million Gene Therapy: The Zolgensma Story
This investigative piece traces the development of Zolgensma, a gene therapy for spinal muscular atrophy that became the world's most expens
propublica.org·2d ago
NIH proposes capping number of grants per scientist to broaden research funding distribution
The U.S. National Institutes of Health (NIH) is proposing to cap the number of research project grants (RPGs) a principal investigator can h
science.org·29d ago
Allen Institute launches $400M Brain Health accelerator to develop genetic therapies for neurodegenerative diseases
The Allen Institute in Seattle has launched the Brain Health accelerator, a $400 million initiative aimed at developing genetic therapies (i
npr.org·1mo ago
Precision gene editing technologies: From proof-of-concept to clinical therapies
This review article examines the evolution of gene therapy from gene addition to precise genome editing, focusing on breakthrough technologi
Comments
Sign in to join the conversation.
No comments yet. Be the first.